The bill, which prohibits the Alabama Board of Medical Examiners and the Medical Licensure Commission of Alabama from taking action, passed unanimously in the state House and Legislature.
Off-label use refers to prescribing an approved drug for an unapproved disease or condition, administering it in a different form or giving it in a different dose.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
